Donanemab approval delayed by US drugs regulator 

The American Food and Drug Administration (FDA) has announced an advisory panel will be convened to scrutinise data on the safety and efficacy of new Alzheimer’s drug donanemab. Donanemab had been expected to be approved by the FDA imminently, but their decision is now delayed until later this year. 

UK regulators (along with their European and Australian counterparts) are still assessing the drug. 

More information here: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-delays-lilly-alzheimers-drug-decision-calls-advisory-panel-2024-03-08/ 

Similar Posts

  • Dementia-friendly Ramadan

    Alzheimer’s Society has produced advice on Ramadan for family carers and they people they care for.  In a blog on its website, the charity sets out what Ramadan is, how it is observed by Muslims, the role of spiritual fasting, how to have a dementia-friendly Ramadan, and the role of social events taking place during…

  • Digital care

    A digital care programme rolled out across the county by Kent Council has won national recognition in the HTN HealthTech Awards.  The project, called Kara, involved successfully equipping 1,700 vulnerable, digitally disadvantaged adults with video “carephones” to overcome social isolation during Covid.  Comprising a one-touch secure tablet device, it provided video-calling to the individual’s support…

  • ‘Safe and found’

    A charity specialising in medical ID jewellery, which is working with the police to trace and support people with dementia who become lost, is offering first year membership free.  MedicAlert UK has launched the “Safe & Found” programme in the UK, in which the charity holds a copy of the Herbert Protocol Form containing a…

  • Care home research

    In what is believed to be a care sector “first”, Dr Isabelle Latham has been appointed researcher in residence by Hallmark Care Homes.  Dr Latham moves to her new role from Worcester University’s Association for Dementia Studies (ADS), where she had a lengthy career as a senior lecturer.  Hallmark is a family-run business with 19…

  • DEEP and tide

    Another report from UK Dementia Congress 2022. DEEP – the Dementia Engagement and Empowerment Project – is a lifeline, said Dory, who told the audience how DEEP groups across the UK had already had 17 in-person celebrations of the organisation’s tenth anniversary this year: “We’re all unique and wonderful but together we’re a masterpiece. For…

  • Marie Curie publish research from end-of-life survey 

    Marie Curie has published their ‘Better End of Life Report 2024’ that’s subtitled: ‘Time to Care: findings from a nationally representative survey of experiences at the end of life in England and Wales’. It’s been compiled by King’s College London’s Cicely Saunders Institute, Hull York Medical School at University of Hull, and the University of…